Expand Document  |  Expand Chapter  |  Full TOC  |  Printable HTML version
The Use of Common Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
(2003; 148 pages) View the PDF document
Table of Contents
View the documentPreface
View the documentAcknowledgements
View the documentReference to the volumes of the WHO Drug Information in which the respective proposed lists of INNs have been published:
View the documentLayout of information
View the documentPharmacological classification with corresponding examples of common stems and their definitions
View the documentAlphabetical list of stems together with corresponding INNs
View the documentAlphabetical list of common stems (INDEX PAGE)
View the documentANNEX 1: INNs for monoclonal antibodies
View the documentANNEX 2: Procedure for the selection of recommended international nonproprietary names for pharmaceutical substances*
View the documentANNEX 3: General principles for guidance in devising international nonproprietary names for pharmaceutical substances*
View the documentWhy INNs?
 

The Use of Common Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances

WHO/EDM/QSM/2003.2
Distr: GENERAL
ENGLISH ONLY

2002


Programme on International Nonproprietary Names (INN)
Quality Assurance and Safety: Medicines
Essential Drugs and Medicines Policy
World Health Organization
Geneva

© World Health Organization [2003]

All rights reserved. Publications of the World Health Organization can be obtained from Marketing and Dissemination, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; email: bookorders@who.int). Requests for permission to reproduce or translate WHO publications - whether for sale or for noncommercial distribution - should be addressed to Publications, at the above address (fax: +41 22 791 4806; email: permissions@who.int).

The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.

The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters.

The World Health Organization does not warrant that the information contained in this publication is complete and correct and shall not be liable for any damages incurred as a result of its use.

THE ORIGINAL AND SUBSEQUENT EDITION OF THIS DOCUMENT HAD THE REFERENCE NUMBER WHO/PHARM S/NOM 15

 

to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: June 25, 2014